Epanolol is an beta blocker.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Epanolol may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Epanolol may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Epanolol. |
| Alfuzosin | Alfuzosin may increase the hypotensive activities of Epanolol. |
| Amifostine | Epanolol may increase the hypotensive activities of Amifostine. |
| Diazoxide | Diazoxide may increase the hypotensive activities of Epanolol. |
| Methylphenidate | Methylphenidate may decrease the antihypertensive activities of Epanolol. |
| Dexmethylphenidate | Dexmethylphenidate may decrease the antihypertensive activities of Epanolol. |
| Obinutuzumab | Epanolol may increase the hypotensive activities of Obinutuzumab. |
| Pentoxifylline | Pentoxifylline may increase the hypotensive activities of Epanolol. |
| Rituximab | Epanolol may increase the hypotensive activities of Rituximab. |
| Desmopressin | Desmopressin may decrease the antihypertensive activities of Epanolol. |
| Zolmitriptan | Zolmitriptan may decrease the antihypertensive activities of Epanolol. |
| Doxapram | Doxapram may decrease the antihypertensive activities of Epanolol. |
| Atropine | Atropine may decrease the antihypertensive activities of Epanolol. |
| Sumatriptan | Sumatriptan may decrease the antihypertensive activities of Epanolol. |
| Naratriptan | Naratriptan may decrease the antihypertensive activities of Epanolol. |
| Rizatriptan | Rizatriptan may decrease the antihypertensive activities of Epanolol. |
| Frovatriptan | Frovatriptan may decrease the antihypertensive activities of Epanolol. |
| Dutasteride | Dutasteride may decrease the antihypertensive activities of Epanolol. |
| Finasteride | Finasteride may decrease the antihypertensive activities of Epanolol. |
| Yohimbine | Yohimbine may decrease the antihypertensive activities of Epanolol. |
| Solifenacin | Solifenacin may decrease the antihypertensive activities of Epanolol. |
| Epicaptopril | Epicaptopril may decrease the antihypertensive activities of Epanolol. |
| 1-benzylimidazole | 1-benzylimidazole may decrease the antihypertensive activities of Epanolol. |
| Amineptine | Amineptine may decrease the antihypertensive activities of Epanolol. |
| Flibanserin | Flibanserin may decrease the antihypertensive activities of Epanolol. |
| Naluzotan | Naluzotan may decrease the antihypertensive activities of Epanolol. |
| Nitrous oxide | Nitrous oxide may decrease the antihypertensive activities of Epanolol. |
| Cinitapride | Cinitapride may decrease the antihypertensive activities of Epanolol. |
| Lurasidone | Lurasidone may decrease the antihypertensive activities of Epanolol. |
| Ifenprodil | Ifenprodil may decrease the antihypertensive activities of Epanolol. |
| Dimetacrine | Dimetacrine may decrease the antihypertensive activities of Epanolol. |
| Butriptyline | Butriptyline may decrease the antihypertensive activities of Epanolol. |
| Moxisylyte | Moxisylyte may decrease the antihypertensive activities of Epanolol. |
| Tianeptine | Tianeptine may decrease the antihypertensive activities of Epanolol. |
| Oxaprotiline | Oxaprotiline may decrease the antihypertensive activities of Epanolol. |
| Atipamezole | Atipamezole may decrease the antihypertensive activities of Epanolol. |
| Tetrahydrocannabivarin | Tetrahydrocannabivarin may decrease the antihypertensive activities of Epanolol. |
| Piclozotan | Piclozotan may decrease the antihypertensive activities of Epanolol. |
| Siponimod | Siponimod may decrease the antihypertensive activities of Epanolol. |
| Idazoxan | Idazoxan may decrease the antihypertensive activities of Epanolol. |
| Amitriptylinoxide | Amitriptylinoxide may decrease the antihypertensive activities of Epanolol. |
| Dibenzepin | Dibenzepin may decrease the antihypertensive activities of Epanolol. |
| Quinupramine | Quinupramine may decrease the antihypertensive activities of Epanolol. |
| Trichloroethylene | Trichloroethylene may decrease the antihypertensive activities of Epanolol. |
| Melitracen | Melitracen may decrease the antihypertensive activities of Epanolol. |
| Lofepramine | Lofepramine may decrease the antihypertensive activities of Epanolol. |
| Xenon | Xenon may decrease the antihypertensive activities of Epanolol. |
| Iprindole | Iprindole may decrease the antihypertensive activities of Epanolol. |
| Buflomedil | Buflomedil may decrease the antihypertensive activities of Epanolol. |
| Diethyl ether | Diethyl ether may decrease the antihypertensive activities of Epanolol. |
| Imipramine oxide | Imipramine oxide may decrease the antihypertensive activities of Epanolol. |
| 5-methoxy-N,N-dimethyltryptamine | 5-methoxy-N,N-dimethyltryptamine may decrease the antihypertensive activities of Epanolol. |
| Quinoline Yellow WS | Quinoline Yellow WS may decrease the antihypertensive activities of Epanolol. |
| Solriamfetol | Solriamfetol may decrease the antihypertensive activities of Epanolol. |
| Sufentanil | Sufentanil may decrease the antihypertensive activities of Epanolol. |
| Isoflurane | Isoflurane may decrease the antihypertensive activities of Epanolol. |
| Propofol | Propofol may decrease the antihypertensive activities of Epanolol. |
| Remifentanil | Remifentanil may decrease the antihypertensive activities of Epanolol. |
| Halothane | Halothane may decrease the antihypertensive activities of Epanolol. |
| Desflurane | Desflurane may decrease the antihypertensive activities of Epanolol. |
| Sevoflurane | Sevoflurane may decrease the antihypertensive activities of Epanolol. |
| Protriptyline | Protriptyline may decrease the antihypertensive activities of Epanolol. |
| Opipramol | Opipramol may decrease the antihypertensive activities of Epanolol. |
| Selpercatinib | Selpercatinib may decrease the antihypertensive activities of Epanolol. |
| Naxitamab | Naxitamab may decrease the antihypertensive activities of Epanolol. |
| Atomoxetine | The risk or severity of hypertension can be increased when Atomoxetine is combined with Epanolol. |
| Linezolid | The risk or severity of hypertension can be increased when Linezolid is combined with Epanolol. |
| Amiodarone | The therapeutic efficacy of Epanolol can be increased when used in combination with Amiodarone. |
| Bupivacaine | The serum concentration of Bupivacaine can be increased when it is combined with Epanolol. |
| Dipyridamole | Dipyridamole may increase the bradycardic activities of Epanolol. |
| Disopyramide | Disopyramide may increase the bradycardic activities of Epanolol. |
| Dronedarone | Dronedarone may increase the bradycardic activities of Epanolol. |
| Fingolimod | Epanolol may increase the bradycardic activities of Fingolimod. |
| Floctafenine | The risk or severity of adverse effects can be increased when Epanolol is combined with Floctafenine. |
| Mepivacaine | The serum concentration of Mepivacaine can be increased when it is combined with Epanolol. |
| Methacholine | Epanolol may increase the bronchoconstrictory activities of Methacholine. |
| Midodrine | The therapeutic efficacy of Midodrine can be decreased when used in combination with Epanolol. |
| Nifedipine | The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Epanolol. |
| Propafenone | The risk or severity of adverse effects can be increased when Propafenone is combined with Epanolol. |
| Regorafenib | Regorafenib may increase the bradycardic activities of Epanolol. |
| Reserpine | Reserpine may increase the hypotensive activities of Epanolol. |
| Deserpidine | Deserpidine may increase the hypotensive activities of Epanolol. |
| Guanethidine | Guanethidine may increase the hypotensive activities of Epanolol. |
| Rivastigmine | Epanolol may increase the bradycardic activities of Rivastigmine. |
| Mirabegron | The serum concentration of Epanolol can be increased when it is combined with Mirabegron. |
| Tedizolid phosphate | Tedizolid phosphate may increase the hypertensive activities of Epanolol. |
| Molsidomine | Molsidomine may increase the hypotensive activities of Epanolol. |
| Insulin argine | Epanolol may increase the hypoglycemic activities of Insulin argine. |
| Remikiren | Remikiren may increase the hypotensive activities of Epanolol. |
| Guanadrel | Guanadrel may increase the hypotensive activities of Epanolol. |
| Carteolol | Carteolol may increase the hypotensive activities of Epanolol. |
| Bosentan | Bosentan may increase the hypotensive activities of Epanolol. |
| Candoxatril | Candoxatril may increase the hypotensive activities of Epanolol. |
| Metyrosine | Metyrosine may increase the hypotensive activities of Epanolol. |
| Cryptenamine | Cryptenamine may increase the hypotensive activities of Epanolol. |
| Dorzolamide | Dorzolamide may increase the hypotensive activities of Epanolol. |
| Bimatoprost | Bimatoprost may increase the hypotensive activities of Epanolol. |
| Pentolinium | Pentolinium may increase the hypotensive activities of Epanolol. |